576
Views
173
CrossRef citations to date
0
Altmetric
Review

Biodegradable polyester elastomers in tissue engineering

, &
Pages 801-812 | Published online: 23 Feb 2005

Bibliography

  • LANGER R, VACANTI JP: Tissue engineering. Science (1993) 260:920–926.
  • WANG Y, AMEER GA, SHEPPARD BJ, LANGER R: A tough biodegradable elastomer. Nat. Biotechnol (2002) 20:602–606.
  • ••First to describe poly(glycerol sebacate).
  • NIKLASON LE, GAO J, ABBOTT WMet al.: Functional arteries grown in vitro. Science (1999) 284:489–493.
  • •First to use biodegradable synthetic polymers and mechanical conditioning to tissue engineer a small diameter blood vessel.
  • NIKLASON LE, ABBOTT W, GAO J et al.: Morphologic and mechanical characteristics of engineered bovine arteries. Vasc. Stag. (2001) 33:628–638.
  • KIM BS, MOONEY DJ: Scaffolds for engineering smooth muscle under cyclic mechanical strain conditions. Biomech. Eng. (2000) 122:210–215.
  • KIM BS, NIKOLOVSKI J, BONADIO J, MOONEY DJ: Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat. Biotechnol (1999) 17:979–983.
  • •Demonstrates the importance of mechanical stimulation during development.
  • NEREM RIVI: Role of mechanics in vascular tissue engineering. Biorheology (2003) 40:281–287.
  • STEGEMANN JP, NEREM PM: Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann. Biomed. Eng. (2003) 31:391–402.
  • XUE L, GREISLER HP: Biomaterials in the development and future of vascular grafts. .1. Vasc. Stag. (2003) 37:472–480.
  • BALLYK PD, WALSH C, BUTANY J, MATADIAL 0: Compliance mismatch may promote graft-artery intimal hyperplasia by altering suture-line stresses. Biomech. (1998) 31:229–237.
  • WESTON MW, RHEE K, TARBELI JM: Compliance and diameter mismatch affect the wall shear rate distribution near and end-to-end anastomosis. Biomech. (1996) 29:187–198.
  • TRUBEL W, SCHIMA H, MORITZ A: Compliance mismatch and formation of distal anastomotic intimal hyperplasia in externally stiffened and lumen adapted venous grafts. Eur. Vasc. Endovasc. Surg. (1995) 10:415–423.
  • WALDEN R, LTFALIEN GJ, MEGERMAN J, ABBOTT WM: Matched elastic properties and successful arterial grafting. Arch. Surg. (1980) 115:1166–1169.
  • MEHIGAN DG, FITZPATRICK B, BROWNE HI, BOUCHIER-HAYES DJ: Is compliance mismatch the major cause of anastomotic arterial aneurysms? Analysis of 42 cases.' Cardiovasc. Stag. (1985) 26:147–150.
  • KIDSON IG: The effect of wall mechanical properties on patency of arterial grafts. Ann. R. Coll. Surg. Engl. (1983) 65:24–29.
  • PEI M, SOLCHAGA LA, SEIDEL J et al.: Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB.I. (2002) 16:1691–1694.
  • WALDMAN SD, SPITERI CG, GRYNPAS MD et al.: Effect of biomechanical conditioning on cartilaginous tissue formation in vitro. J. Bone Joint Surg. Am. (2003) 85A:101–105.
  • DARLING EM, ATHANASIOU KA: Articular cartilage bioreactors and bioprocesses. Tissue Eng. (2003) 9:9–26.
  • LEE JH, KISIDAY J, GRODZINSKY AJ:Tissue-engineered versus native cartilage: linkage between cellular mechano-transduction and biomechanical properties. Novartis Found. Symp. (2003) 249:52–64.
  • FROMSTEIN JD, WOODHOUSE KA: Elastomeric biodegradable polyurethane blends for soft tissue applications. Biomater. Sci. Polym. Ed. (2002) 13:391–406.
  • GUAN J, SACKS MS, BECKMAN EJ, WAGNER WR: Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly (ester-urethane)ureas based on poly(caprolactone) and putrescine. Biomed. Mater. Res. (2002) 61:493–503.
  • MCDEVITT TC, WOODHOUSE KA, HAUSCHKA SD, MURRY CE, STAYTON PS: Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. Biomed. Mater. Res. (2003) 66A:586–595.
  • SKARJA GA, WOODHOUSE KA: Synthesis and characterization of degradable polyurethane elastomers containing an amino acid-based chain extender. In: Polymers for Tissue Engineering Shoichet MS, Hubbell JA (Eds), VSP, Utrecht, The Netherlands (1998):73–79.
  • TAMURA T, YAMAOKA T, KUNUGI S, PANITCH A, TIRRELL DA: Effects of temperature and pressure on the aggregation of properties of an engineered elastin model polypeptide in aqueous solution. Biomacromolecules (2000) 1:552–555.
  • WELSH ER, TIRREL DA: Engineering the extracellular matrix: a novel approach to polymeric biomaterials. I. Control of the physical properties of artificial protein matrices designed to support adhesion of vascular endothelial cells. Biomacromolecules (2000) 1:23–30.
  • URRY DW, PATTANAIK A, XIE J et al.: Elastic protein-based polymers in soft tissue augmentation and generation..! Biomater. Sci. Polym. Ed (1998) 9:1015–1048.
  • LEE J, MACOSKO CW, URRY DW: Elastomeric polypentapeptides cross-linked into matrixes and fibers. Biomacromolecules (2001) 2:170–179.
  • URRY DW, PATTANAIK A: Elastic protein-based materials in tissue reconstruction. Ann. NY Acad. Sci. (1997) 831:32–46.
  • PACHENCE JM, KOHN J: Biodegradablepolymers. In: Principles of Tissue Engineering. Lanza RP, Langer R, Vacanti JP (Eds), Academic Press, San Diego, USA (2000):263–277.
  • SODIAN R, HOERSTRUP SP, SPERLING JS et al.: Early M vivo experience with tissue-engineered trileaflet heart valves. Circulation (2000) 102:11122–11129.
  • STEINBUCHEL A: Production of rubber-like polymers by microorganisms. Carr. Opin. Microbial. (2003) 6:261–270.
  • MADISON LL, HUISMAN GW: Metabolic engineering of poly(3-hydroxyalkanoates): from DNA to plastic. Microbial. Ma Biol. Rev (1999) 63:21–53.
  • STEINBUCHEL A, FUCHTENBUSCH B, GORENFLO V et al.: Biosynthesis of polyesters in bacteria and recombinant organisms. Polym. Degr. Stab. (1998) 59:177–182.
  • ZINN M, WITHOLT B, EGLI T: Occurrence, synthesis, and medical application of bacterial polyhydroxyalkanoate. Adv. Drug Deify. Rev (2001) 53:5–21.
  • •Good review of PHAs and medical applications.
  • WILLIAMS SF, MARTIN DP, HOROWITZ DM, PEOPLES OP: PHA applications: addressing the price performance issue: I. Tissue engineering. Int. J. Biol. Macromol (1999) 25:111–121.
  • •Good review of PHAs for tissue engineering.
  • REDDY CS, GHAJ R, RASHMI, KALIA VC: Polyhydroxyalkanoates: an overview. Biores. Tech. (2003) 87:137–146.
  • •Good review of PHAs.
  • STEINBUCHEL A, FUCHTENBUSCH B: Bacterial and other biological systems for polyester production. Trends Biotech. (1998) 16:419–427.
  • ALDOR IS, KEASLING JD: Process designfor microbial plastic factories: metabolic engineering of polyhydroxyalkanoates. Carr. Opin. Biotechnol (2003) 14:475–483.
  • MARTIN DP, WILLIAMS SF: Medical applications of poly-4-hydroxybutyrate: a strong flexible absorbable biomaterial. Biochem. Eng. J. (2003) 16:97–105.
  • ••Good review of P4HB.
  • HOCKING PJ, MARCHESSAULT RH: In: Chemistry and Technology of Biodegradable Polymers. Griffin GJL (Ed.), Chapman and Hall, London, UK (1994):48.
  • STOCK UA, NAGASHIMA M, KHALIL PN et al.: Tissue-engineered valved conduits in the pulmonary circulation. J. Thome. Cardiovasc. Surg. (2000) 119:732–740.
  • HOERSTRUP SP, SODIAN R, DAEBRITZ S et al.: Functional living trileaflet heart valves grown M vitro. Circulation (2000) 102:11144–11149.
  • •Use of PHA/synthetic polymer matrix for in vitro tissue engineering of heart valves.
  • HOERSTRUP SP, SODIAN R, SPERLING JS, VACANTI JP, MAYER JE JR: New pulsatile bioreactor for M vitro formation of tissue engineered heart valves. Tissue Eng. (2000) 6:75–79.
  • STOCK UA, SAKAMOTO T, HATSUOKA S et al.: Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. J. Thome. Cardiovasc. Surg. (2000) 120:1158-1167; discussion 1168.
  • RELKIN N, NELSON T: The extraneural distribution of gamma-hydroxybutyrate. J. Neurochem. (1983) 40:1639–1646.
  • SENDELBECK SL, GIRDIS CL: Disposition of a 14C-labeled bioerodible polyorthoester and its hydrolysis products, 4-hydroxybutyrate and cis,trans-1,4-bis(hydroxymethyl)cyclohexane, in rats. Drug Metab. Dispos. (1985) 13:291–295.
  • SHUM-TIM D, STOCK U, HRKACH J et al.: Tissue engineering of autologous aorta using a new biodegradable polymer. Ann. Thorac Surg. (1999) 68:2298–2305.
  • •Use of PHO/synthetic polymer matrix for in vivo tissue engineering of blood vessels.
  • STOCK U, WIEDERSCHAIN D, KILROY SM et al.: Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures.Biochem. (2001)81:220–228.
  • ZHAO K, DENG Y, CHEN JC, CHEN G-Q: Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility. Biomaterials (2003) 24:1041–1045.
  • ••Describes PHBHHx:PHB blendsand biocompatibility.
  • DENG Y, ZHAO K, XIONG-FEI, HU P, CHEN G-Q: Study on the three-dimensional proliferation of rabbit articular cartilage-derived chondrocytes on polyhydroxyalkanoate scaffolds. Biomaterials (2002) 23:4049–4056.
  • KUNIOKA M, KAWAGUCHI Y, DOI Y: Production of biodegradable copolyesters of 3-hydroxybuyrate and 4-hydroxybutyrate by Akaligenes eutrophus. Appl Microbial. Biotechnol (1989) 30:569–573.
  • BEZWADA RS, JAMIOLKOWSKI DD, LEE IY et al: Monocryl suture, a new ultra-pliable absorbable monofilament suture. Biomaterials (1995) 16:1141–1148.
  • DARNEY PD, MONROE SE, KLAISLE CM, ALVARADO A: Clinical evaluation of the Capronor contraceptive implant: preliminary report. Am. J Obstet. Cynecol. (1989) 160:1292–1295.
  • PITT CG, GRATZL MM, KIMMEL GL, SURLES J, SCHINDLER A: Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo. Biomaterials (1981) 2:215–220.
  • WOODWARD SC, BREWER PS, MOATAMED F, SCHINDLER A, PITT CG: The intracellular degradation of poly(epsilon-caprolactone). Biomed. Mater. Res. (1985) 19:437–444.
  • LANG M, BEI J, WANG S: Synthesis and characterization of polycaprolactone/ poly(ethylene oxide)/polylactide tri-component copolymers. J Biomater. Sci. Polym. Ed. (1999) 10:501–512.
  • JUNI K, NAKANO M: Poly(hydroxy acids) in drug delivery. Crit. Rev Ther. Drug Carrier Syst. (1987) 3:209–232.
  • CHEN CC, CHUEH JY, TSENG H, HUANG HM, LEE SY: Preparation and characterization of biodegradable PLA polymeric blends. Biomaterials (2003) 24:1167–1173.
  • LEE SH, KIM BS, KIM SH et al.: Elastic biodegradable poly(glycolide-co-caprolactone) scaffold for tissue engineering. j. Biorned. Mater. Res. (2003) 66A:29–37.
  • ••One of the first reports to describe PGCLfor tissue engineering.
  • TSUJI H, IKADA Y: Blends of aliphatic polyesters. 1. Physical properties and morphologies of solution-cast blends from poly(DL-lactide) and poly(epsilon-caprolactone). Appl. Polym. Sci. (1996) 60:2367–2375.
  • WADA R, HYON SH, NAKAMURA T, IKADA Y: ha vitro evaluation of sustained drug release from biodegradable elastomer. Pharm. Res. (1991) 8:1292–1296.
  • MATSUMURA G, MIYAGAWA-TOMITA S, SHIN'OKA T, IKADA Y, KUROSAWA H: First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation (2003) 108:1729–1734.
  • •Describes the use of poly(caprolactone)-based polymers for tissue engineering in humans.
  • MATSUMURA G, HIBINO N, IKADA Y, KUROSAWA H, SHIN'OKA T: Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials (2003) 24:2303–2308.
  • WATANABE M, SHIN'OKA T, TOHYAMA S et al.: Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng. (2001) 7:429–439.
  • SHIN'OKA T, IMAI Y, IKADA Y: Transplantation of a tissue-engineered pulmonary artery. N Engl. I Med. (2001) 344:532–533.
  • PEGO AP, POOT AA, GRIRMA DW, FEIJEN J: Biodegradable elastomeric scaffolds for soft tissue engineering. Control. Release (2003) 87:69–79.
  • ••Good review of trimethylene carbonate-based polymers.
  • PEGO AP, POOT AA, GRIJPMA DW, FEIJEN J: Copolymers of trimethylene carbonate and epsilon-caprolactone for porous nerve guides: synthesis and properties.j Biomatec Sci. Polym. Ed (2001) 12:35–53.
  • PEGO AP, SIEBUM SB, LUYN MJAV et al.: Preparation of degradable porous structures based on 1,3-trimethylene carbonate and D,L-lactide (co)polymers for heart tissue engineering. Tissue Eng. (2003) 9:981–994.
  • MACKINNON SE, DELLON AL: A studyof nerve regeneration across synthetic (Maxon) and biologic (collagen) nerve conduits for nerve gaps up to 5 cm in the primate. Reconstr. Microsurg. (1990) 6:117–121.
  • FABRE T, SCHAPPACHER M, BAREILLE R et al.: Study of a (trimethylenecarbonate-co-epsilon-caprolactone) polymer-part 2: in vitro cytocompatibility analysis and in vivo ED1 cell response of a new nerve guide. Biomaterials (2001) 22:2951–2958.
  • ENGELBERG I, KOHN J: Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials (1991) 12:292–304.
  • MAY JW JR, LARGIS JK, KATZ AR: An absorbable catheter system for use in microvascular and peripheral vascular surgery: an experimental study in the canine. Plast. Reconstr. Surg. (1992) 89:299–305.
  • KATZ AR, MUKHERJEE DP, KAGANOV AL, GORDON S: A new synthetic monofilament absorbable suture made from polytrimethylene carbonate. Surg. Cynecol Obstet. (1985) 161:213–222.
  • CHU CC, KIZIL Z: Quantitative evaluation of stiffness of commercial suture materials. Surg. Cynecol Obstet. (1989) 168:233–238.
  • PEGO AP, GRIRMA DW, FEIJEN J: Enhanced mechanical properties of 1,3 trimethylene carbonate polymers and networks. Polymer (2003) 44:6495–6504.
  • PEGO AP, LUYN MJAV, BROUWER LA et al: Li vivo behavior of poly (1, 3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with D,L-lactide or e-caprolactone: Degradation and tissue response. Biomed. Mater. Res. (2003) 67A:1044–1054.
  • PEGO AP, POOT AA, GRIRMA DW, FEIJEN J: Physical properties of high molecular weight 1,3-trimethylene carbonate and D,L-lactide copolymers. J. Mater. Sci. Mat. Med. (2003) 14:767–773.
  • PEGO AP, POOT AA, GRIRMA DW, FEIJEN J: In vitro degradation of trimethylene carbonate based (co) polymers. Macromol Biosci. (2002) 2:411–419.
  • BOS RRM, ROZEMA FB, BOERING G et al.: Degradation of and tissue reaction to biodegradable poly(L-lactide) for use as internal fixation of fractures: a study in rats. Biomaterials (1991) 12:32–36.
  • PEGO AP, VLEGGEERT-LANKAMP CL, DEENEN Metal.: Adhesion and growth of human Schwann cells on trimethylene carbonate copolymers. Biomed. Mater. Res. (2003) 67A:876–885.
  • NAGATA M, KIYOTSUKURI T, IBUKI H, TSUTSUMI N, SAKAI W: Synthesis and enzymatic degradation of regular network aliphatic polyesters. React. Func. Polym. (1996) 30:165–171.
  • NAGATA M, MACHIDA T, SAKAI W, TSUTSUMI N: Synthesis characterization and enzymatic degradation of network aliphatic copolyesters. Polym. Sci. A: Polym. Chem. (1999) 37:2005–2011.
  • •First to describe glycerol and sebacic acid copolymers, although not for tissue engineering.
  • LIU G, HINCH B, BEAVIS AD: Mechanisms for the transport of alpha,omega-dicarboxylates through the mitochondrial inner membrane. I Biol. Chem. (1996) 271:25338–25344.
  • GREGO AV, MINGRONE G: Dicarboxylic acids, an alternate fuel substrate in parenteral nutrition: an update. Nutr. (1995) 14:143–148.
  • MORTENSEN PB: C6-C10 dicarboxylic aciduria in starved, fat-fed and diabetic rats receiving decanoic acid or medium-chain triacylglycerol. An in vivo measure of the rate of beta-oxidation of fatty acids. Biochim. Biophys. Acta (1981) 664:349–355.
  • FU J, FIEGEL J, KRAULAND E, HANES J: New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials (2002) 23:4425–4433.
  • GOSLINE J, LILLIE M, CARRINGTON E et al.: Elastic proteins: biological roles and mechanical properties. Phil Trans. R. Soc. Lond. B (2002) 357:121–132.
  • WANG Y, KIM YM, LANGER R: In vivo degradation characteristics of poly (glycerol sebacate). Biomed. Mater. Res. (2003) 66A:192–197.
  • GOPFERICH A: Mechanisms of polymer degradation and erosion. Biomaterials (1996) 17:103–114.
  • YANG J, WEBB A, AMEER G: Novel citric acid-based biodegradable elastomers for tissue engineering. Adv. Mater. (2004) 16:511–516.
  • ••First to describe poly(diol citrates).
  • LEE MC, HAUT RC: Strain rate effects ontensile failure properties of the common carotid artery and jugular veins of ferrets. Biomech. (1992) 25:925–927.
  • NUGENT HM, EDELMAN ER: Tissue engineering therapy for cardiovascular disease. Circ. Res. (2003) 92:1068–1078.
  • PARIKH SA, EDELMAN ER: Endothelial cell delivery for cardiovascular therapy. Adv. Drug Deify. Rev (2000) 42:139–161.
  • WONG JY, VELASCO P, RAJAGOPALAN P, PHAM Q: Directed movement of vascular smooth muscle cells on gradient compliant hydrogels. Langmuir (2003) 19:1908–1913.
  • RAJAGOPALAN P, MARGANSKI W, DEMBO M, WONG JY: Traction stresses and morphology of 3T3 fibroblast cells on fibronectin versus RGD modified elastic substrata. Mat. Res. Soc. Proc. (2002) 711:231–237.
  • SELIKTAR D, BLACK RA, VITO R, NEREM RM: Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann. Biorned. Eng. (2000) 28:351–362.
  • SELIKTAR D, NEREM RM, GALIS ZS: The role of matrix metalloproteinase-2 in the remodeling of cell-seeded vascular constructs subjected to cyclic strain. Ann. Biorned. Eng. (2001) 29:923–934.
  • BUSCHMANN MD, KIM YJ, WONG M et al.: Stimulation of aggrecan synthesis in cartilage explants by cyclic loading is localized to regions of high interstitial fluid flow. Arch. Biochem. Biophys. (1999) 366:1–7.
  • BUSCHMANN MD, GLUZBAND YA, GRODZINSKY AJ, HUNZIKER EB: Mechanical compression modulates matrix biosynthesis in chondrocyte/agarose culture. J. Cell Sci. (1995) 108:1497–1508.
  • KIM YJ, SAH RL, GRODZINSKY AJ, PLAAS AH, SANDY JD: Mechanical regulation of cartilage biosynthetic behavior: physical stimuli. Arch. Biochem. Biophys. (1994) 311:1–12.
  • YANG S, LEONG K, DU Z, CHUA C: The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. (2001) 7:679–689.
  • MILLESI H, ZOCH G, REIHSNER R: Mechanical properties of peripheral nerves. Orthop. (1995) 314:76–83.
  • DAHMS SE, PIECHOTA HJ, DAHIYA R, LUE TF, TANAGHO EA: Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig, and human. Br: J. [Ira (1998) 82:411–419.
  • GIRTON TS, OEGEMA TR, GRASSL ED, ISENBERG BC, TRANQUILLO RT: Mechanisms of stiffening and strengthening in media-equivalents fabricated using glycation. Bioinech. Eng. (2000) 46:87–92.
  • SUNG H-W, CHANG Y, CHIU C-T, CHEN C-N, LIANG H-C: Mechanical properties of a porcine aortic valve fixed with a naturally occurring crosslinking agent. Biomaterials (199) 20: 1759-1772.
  • CHANDRAN KB: Cardiovascular Biomechanics. Chandran KB (Ed.), New York University Press, New York, USA (1992).
  • MARTIN DP, WILLIAMS SF, SKRALY FA: Polymers biosynthesized by microorganisms: polyhydroxyalkanoates. In: Methods of Tissue Engineering. Atala A, Lanza RP (Eds), Academic Press, San Diego, USA (2002):575–583.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.